| Financial Year |
March 31 2023 |
| Monetary Funds |
2,897,400,855.28 |
| Held-for-trading Financial Assets |
905,316,416.11 |
| Notes Receivable |
-- |
| Accounts Receivable |
139,097,851.37 |
| Advances to Suppliers |
27,481,965.83 |
| Other Receivables |
5,476,047.93 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
37,847,042.51 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
93,128,257.78 |
| Total Current Assets |
4,105,748,436.81 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
929,572,165.72 |
| Investment Properties |
-- |
| Fixed Assetes |
192,509,445.66 |
| Under-construction Projects |
17,183,812.17 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
114,836,139.60 |
| R&D expenses |
-- |
| Goodwill |
244,891,105.88 |
| Long-Term Deferred and Prepaid Expenses |
37,143,571.97 |
| Deferred Income Tax Assets |
9,787,191.03 |
| Other Non-Current Assets |
48,610,452.59 |
| Sub-Total of Non-Current Assets |
2,577,439,903.75 |
| Total Assets |
6,683,188,340.56 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
23,582,809.50 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
59,302,195.04 |
| Taxes Payable |
38,652,281.75 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
33,230,502.48 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
14,233,999.55 |
| Other Current Liabilities |
507,355.40 |
| Sub-Total of Current Liabilities |
197,836,016.50 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
36,423,207.33 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
93,670,921.27 |
| Total Liabilities |
291,506,937.77 |
| Paid-In Capital(Or Share Stock) |
216,360,000.00 |
| Capital Surplus |
3,411,863,628.55 |
| Surplus Reserve |
108,180,000.00 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
2,521,256,569.64 |
| Minority Stockholder's Interest |
139,554,899.40 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
6,252,126,503.39 |
| Owner's Equity（Stockholder's Equity） |
6,391,681,402.79 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
6,683,188,340.56 |
